Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study

Martin R. Gaudinski, Emily E. Coates, Laura Novik, Alicia T. Widge, Katherine V. Houser, Eugeania Burch, LaSonji A. Holman, Ingelise J. Gordon, Grace Chen, Cristina Carter,

The Lancet · 2019 · 128 citations · 29 references

DOIFull text

Open access

Concepts

References

29